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Purpose:  IMRT (intensity modulated radiotherapy) verification techniques are reviewed 
together with investigations, demonstrating the intrinsic verification problems. 
Material and Methods: Different IMRT verification procedures for either class solutions or 
individual patients are demonstrated. Among the latter are techniques like fluence or 3D-dose 
distribution verification within a transfer phantom. Different radiographic films and absolute 
dose probes are investigated for their suitability. Finally Monte Carlo techniques  
(XVMC/VEF) are used for error detection and IMRT verification. 
Results: During introduction of clinical IMRT for head and neck (H&N) tumors we 
concurrently applied fluence, relative and absolute dose measurement in parallel. While 
fluence and relative dose are in rather good agreement with calculations, absolute dose is 
always low compared to the TPS (TMS 6.1A, Nucletron B.V.) by 5-7 %. This deviation 
seems to depend not on the number of segments, but can strongly depend on MLC 
misalignment. Further investigations have revealed the importance of a detailed 
commissioning of the TPS down to the small-field range using diamond or diode probes and 
its detailed verification. In addition simple tests have shown that dose calculation 
approximations in the IMRT option of TMS are one major source of the dose deviation. 
XVMC/VEF does not use such approximations. 
Conclusion: The procedure starts with a detailed TPS commissioning and verification 
process. Different verification methods are recommended during clinical IMRT 
implementation phase in order to locate sources of error. Later on, a minimal program could 
consist of a fluence or a relative dose verification procedure with few films and absolute dose 
measurement, followed by an intensive MLC quality assurance (QA). Inverse Monte Carlo 
systems like IMCO++/IKO or Hyperion, seem to be able to reduce the effort. 
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Verifikation der IMRT: Techniken und Probleme 
 
Ziel: Neben einem Überblick über Verifikationstechniken der IMRT (intensitätsmodulierten 
Radiotherapie) werden Untersuchungen zu intrinsischen Verifikationsproblemen gezeigt. 
Material und Methodik: Verschiedene Verifikationsmethoden für Klassenlösungen sowie 
für individuelle Patientenpläne werden demonstriert, wie etwa Fluenz- und  dreidimensionale 
Dosisverteilungen in einem Ersatzphantom. Dazu werden verschiedene Radiographiefilme 
und Absolutdosissonden auf ihre Eignung untersucht. Monte Carlo Techniken (XVMC/VEF) 
werden zur Fehleranalyse eingesetzt und auf ihre Tauglichkeit zur Verifikation untersucht.  
Ergebnisse: Bei der klinischen Einführung der IMRT bei Kopf-Hals- Tumoren wurden 
parallel Fluenz-, relativ- und absolutdosimetrische Verfahren zur Verifikation angewandt. 
Während die Fluenz- und Dosisverteilungen gut mit den Berechnungen übereinstimmen, sind 
die Absolutdosen systematisch um 5-7% niedriger als die mit dem TPS (TMS 6.1A) 
berechneten. Die Abweichung scheint nicht von der Gesamtzahl der Segmente des Plans 
abzuhängen, kann aber relativ stark aber von einer relativ geringen Abweichung der MLC- 
Leaves vom Sollwert abhängen. Weitere Untersuchungen zeigen auf, wie wichtig eine 
detaillierte TPS-Kommissionierung bis in den Bereich kleiner Feldgrößen mit umfangreichen 
Verifikationen und einfachen Tests ist. Damit konnte ein wichtiger Beitrag zum Dosisfehler, 
nämlich zusätzliche Näherungen bei der Dosisberechnung von IMRT-Plänen, verantwortlich 
gemacht werden. XVMC/VEF verwendet keine derartigen  Näherungen.  
Schlussfolgerung: Die Prozedur beginnt mit einer detaillierten TPS-Kommisionierung und 
Verifikation. Während der klinischen Einführungsphase sollten unterschiedliche 
Verifikationsverfahren eingesetzt werden, um etwaige Fehler aufzuspüren. Später kann ein 
Minimalprogramm verwendet werden, das entweder aus Fluenz- oder Relativdosismessungen 
in Verbindung mit einer Absolutdosisbestimmung besteht. Unabhängig davon sollte eine 
intensive Qualitätssicherung (QS) des MLCs erfolgen. Inverse Monte Carlo Systeme wie 
IMCO++/IKO oder Hyperion sind vermutlich geeignet, den Aufwand beträchtlich zu 
reduzieren. 
 
Schlüsselwörter: IMRT, Verifikation, QS, Monte Carlo, TPS-Kommissionierung 
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Introduction 
While IMRT treatments of patients started some years ago in the USA, the introduction into 
clinical routine has proceeded much slower in Germany. In the meantime, some institutions 
have obtained experience in IMRT treatments, and a large community of radiation oncology 
departments are in the starting phases. 
 
Many methods for small-field dosimetry in IMRT, such as those using different dosimeters 
like TLDs, semiconductor diodes, diamond detectors or ionisation chambers with small 
volumes have been tested (e.g. [19]). Verification methods for use in clinical practice were 
recently published by Ezell et al. [8], MacKenzie et al.[23], Rhein et al. [25] and others. 
There is a critical review within a report of the IMRT Collaborative Working Group of the 
National Cancer Institute of USA [5], which contains a summary of IMRT-verification 
methods and their problems. 
 
The purpose of this paper is to give an overview over IMRT verification strategies and 
methods, demonstrated on head and neck (H&N) cancer cases. The investigations have 
revealed weak links in the entire chain of therapy planning system (TPS) commissioning -
treatment planning – delivery - verification and yield a critical assessment of what can be 
used to minimize errors in IMRT dose delivery. Finally, we derive a verification procedure, 
which seems reliable and practicable.  
 
Material and Methods 
IMRT Method 
The treatment of H&N cancers by means of  IMRT was started in 2002, by using a seven  
beam technique equally spaced in the posterior hemisphere according to Hunt et al. [16] with 
gantry angles from  90° to 270° in 30° steps. A conventional anterior supraclavicular field is 
then added caudal to the IMRT part by means of a half beam technique. This additional field 
is not included in the fluence optimisation but in the weight optimisation in order to prevent 
under- or overdosage in the junction area (see Figure 6). For optimisation an extended 
planning target volume (EPTV) is used, defined by the application of an isotropic margin of 
0.5 cm around the PTV. On the other hand the mean dose in the PTV is normalized to 100 %.  
One or both parotid glands, the spinal cord, the brain stem and the unspecified tissue outside 
the EPTV plus organs at risk (OARs) are included in the optimisation as OARs.  Spinal cord 
and brain stem are extended by an isotropic safety margin of 0.7 cm.  In the objective 
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function, dose-volume constraints are applied to all OARs. Two separate treatment protocols 
are under investigation. One applies a sequential boost technique with the same seven-field 
IMRT technique used in the preceding large-volume IMRT treatment. The other one makes 
use of a simultaneous integrated boost technique (SIB), as described by Wu et al. [31].  A 
precise patient setup is achieved by means of a stereotactic localization technique (H&N 
mask system, BrainLAB). 
 
IMRT Verification Strategies 
Since IMRT is a sophisticated task for treatment planning as well as for realization of the 
treatment, a reliable quality assurance (QA) of the dose distribution within the patient is of 
extraordinary importance. The authors of the above mentioned report [5] stress that IMRT 
dose distributions are characterized by complex three-dimensional (3-D) dose gradients and a 
time-dependent fluence delivery, placing severe limitations on the dosimeters and techniques. 
They claim that, even today, the ionization chamber is a benchmark probe for IMRT dose-
point measurements. Additionally, radiographic film dosimetry  is the tool of choice for 2-D 
dosimetry, taking into account that even relative dosimetry is a difficult task.  
 
The clinical implementation of IMRT in H&N tumor treatment revealed a variety of 
problems. First of all, dose calculation by means of pencil beam model with IMRT-specific 
approximations and disregarding small-field problems [1] (Ahnesjö 2002, personal 
communication; Murmann 2003, personal communication) is possibly too inaccurate in order 
to achieve reliable results in an inhomogeneous medium in case of very small fields or field 
segments, which results from a high resolution fluence segmentation. Deficiency in lateral 
scatter calculation algorithms leads not only to a systematic error, but additionally to a 
convergence error [17]. The latter originates from the reaction of the optimization process to 
dose errors by compensating them in an erroneous modification of the fluence distributions. 
 
Another issue regarding the accuracy of treatment planning systems is the inappropriate 
modelling of treatment head details, which, in fact, turns out to strongly influence the 
accuracy of output factors and beam profiles in case of small irregular fields, especially in 
off-axis positions. It seems that the requirements for commissioning of IMRT should be 
similar to the process used in stereotactic radiosurgery. Commissioning data set must be 
carefully examined, if the requirements for IMRT are met. The profiles should be measured 
with suited detectors, like microchamber, diode or diamonds. Output factors should be 
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measured down to the smallest possible segment size. Simple multileaf modulated beams 
should be generated and the absolute dose verified in a slab phantom. These subbeams should  
be calculated as single fields as well, because different algorithms are often used for 
modulated as opposed to unmodulated beams.    
These are some reasons why careful and multiple verification methods of IMRT treatment 
plans must be done to try to separate the different sources of inaccuracies and to correlate 
them to TPS, verification- or delivery-associated problems. From such a study,  reliable 
verification techniques can presumably be derived, and remaining TPS-associated errors can 
be explained and regarded for corrections.  
IMRT plan verification would require, in principle, an inhomogeneous anthropomorphic 
phantom identical to the patient. A realistic solution of the problem could be a separation of 
the problem into a two-step procedure, starting a new treatment technique for a distinct 
tumour entity and site with a class solution verification method. After having investigated the 
overall accuracy of the IMRT class solution, simpler methods have to be applied before each 
individual patient treatment in order to verify it. 
 
Verification of Class Solutions 
A classical method for verification of class solutions is the application of the treatment 
technique to a RANDO phantom and applying TLDs, in combination with radiographic 
film dosimetry, to it (e.g. [23]). With this method, a quasi-3-D dose verification can be 
established with reasonable accuracy. Special care must be taken of TLD response beam 
quality factors in different depths of a mixed multiple-beam setup. A very new and promising 
technique, especially suitable for true 3-D dose distributions with high dose gradients, is gel 
dosimetry. This method  avoids the discontinuous measurement of  TLD, where accidental 
hot or cold spots could remain undetected. Fricke or polymer gels are active integrating 
dosimeter substances, which can be brought to any shape within an anthropomorphic mold. 
Whereas Fricke gel can principally be applied in inhomogeneous anthropomorphic phantoms, 
including active lung gels [12, 26], they offer one severe disadvantage. Steep dose gradients 
change with time due to ionic diffusion effects. Polymer gels, on the other hand,  reveal the 
opposite behaviour, because they are too sensitive to oxygen to be used as active measuring 
gels for lungs. On the other hand, diffusion is not an issue for this gel family [6]. In spite of 
this very promising research on so-called normoxic polymer gels will make ideal 3-D gel-
dosimeters available in future. 
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Another technique of dose verification is becoming interesting, as computer hardware gets 
more and more powerful: the Monte Carlo (MC) dose simulation [15, 20, 22]. MC techniques 
are said to be the most precise dose engines, because, in principle, their accuracy depends 
only on the number of  photons sampled [9]. A remaining problem is, as in the case of 
convolution-based algorithms, the necessity of a very detailed treatment head model and its 
commisioning in order to correctly describe output factors and beam profiles of small 
irregular fields. Once having benchmarked a MC code, this method will be perhaps the most 
reliable technique for class solution dose verification in future. 
 
Verification of Individual Patient Plans 
Verification of treatment plans, individually for each patient, can basically be done by two 
different methods. The possibly easier way consists of the measurement of the fluence 
distribution separately for each modulated treatment field, but the task group report [5] 
stresses, that “ as no mechanism currently exists for independently verifying that the 
delivered fluence yields the desired dose distribution, an independent determination of the 
measured and calculated dose distribution coordinates is essential”. In any case, even after 
succeeding to prove that it is sufficient to verify the fluence distributions of all fields, an 
absolute dose determination in at least at one suitable point within a smoothly modulated area 
of each field by ionization chamber (IC) dosimetry or another reliable probe is mandatory. 
Because of the remaining inaccuracies of the TPS, described above, comparisons of these 
point doses with the correlated calculated doses must be regarded within an accuracy 
evaluation concept.  
 
Moreover, as pointed out by the Ttask Group report, the calculated dose distribution must be 
accessed by an appropriate measurement. The only way to do this consists of a transfer of the 
optimized treatment plan to an easy accessible water equivalent or inhomogeneous phantom 
(transfer phantom). The shape and size of this phantom should be somewhat correlated with 
the shape of the treated area of  the patient. This can be, in case of H&N tumors, a solid water 
cylinder with a diameter of approximately 20 cm. Such a phantom is easily accessible to 
dosimetry by radiographic films and absolute dose measurements by suitable probes for dose 
comparisons with calculated date (Figure 1). A still open question is, however, how sensitive 
calculation errors arising from the incorrectly handled lateral scatter components by the TPS 
can be detected in a homogeneous phantom.  
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Dosimeters, Phantoms, and Evaluation Tools for IMRT Verification 
As a simple TPS IMRT commissioning test we used nine equally weighted non-overlapping 
3x3 cm2 subfields to build a 9x9 cm2 field. The dose was then measured with 0.3 cm³ IC 
(M23332, PTW), diamond (M6003, PTW) and dosimetry diode (M60008, PTW) in a slab 
phantom (RW3, PTW) at the isocenter in 10 cm depth. The test case was planned as 
modulated beam with 1 Gy in the isocenter. Additionally, the example was calculated as one 
plan with the 9 single unmodulated fields.  
Radiographic film dosimetry seems to be an easy task, but actually it has to be done 
extremely careful. One of the reasons is that most film materials, which are not water 
equivalent, are very sensitive to low-energy photons, produced in the process of depth 
penetration of a photon. Film dosimetry is, in principle, suitable for both verification methods 
described above.  
Measurements of fluence distributions by means of film dosimetry are usually done in a 
water-equivalent slab phantom in a distinct depth, with the beam direction perpendicular to 
the plane of the film. The measurement within a phantom beyond the depth dose maximum as 
opposed to in-air measurements seems to be mandatory. Reasons are that the contributions of 
contaminant electrons and low-energy photons are not guaranteed to be constant and minor 
for all cases. In addition, the optical density of the film after irradiation only correlates with 
the dose, which itself is only proportional to the photon fluence, when a local secondary 
electron equilibrium exists [18]. Yet, comparisons of in-air and in-phantom  investigations of 
fluence distributions, measured by means of a radiographic film (EDR2, Kodak) reveal only a 
minor difference  in the order of  < 2 % . For this kind of investigation, with perpendicular 
beam entrance to film plane, the choice of film type is not really essential, as long as one 
corrects properly the dependence of the optical density to the dose. In Figure 2, the results of  
four different radiographic films (Kodak X-OMAT, Kodak EC-V, CEA TVS, and Kodak 
EDR2) are presented. With the exception of the X-OMAT film, all reveal a relatively high 
linear response, but using a non-linear fit procedure makes almost all of them suitable, 
depending on the desired dose range. The CEA TVS film is suitable only up to 0,5 Gy. 
Additional investigations on the EDR2 film dose-response curves from different phantom 
depths, shown in Figure 3, reveal no real dependence, but  can be attributed to differences in 
film processing. A similar shift can be observed in a long-term investigation of dose-response 
curves in a phantom in constant depth. This effect is corrected during dose determination. 
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The situation changes completely when applying film dosimetry to 3-D dose investigations 
within a transfer phantom, because in coplanar IMRT techniques, all beam angles are parallel 
to the plane of the film. It is well known that in such a situation low-energy photons, 
increasingly produced with increased depth, result in a higher response of the film, such 
leading to dose errors of up to 20%. In an earlier study we have investigated filter methods 
for parallel beam angles by use of a 0.6mm thick lead-filter, positioned symmetrically 5mm 
from the film within the water-equivalent slab phantom, such yielding  fairly good agreement 
within 7 % with ionisation chamber curves in the range > 1.5 cm .  On the other hand, much 
better agreement without any filter at all is shown by the EDR2 film, in the depth range of 1-
18 cm with a dose deviation to ionization chamber measurement < 4% (Figure 4). 
Additionally, EDR2 can be used as an absolute dosimeter within an accuracy of about +-3%. 
Similar to the procedure of Rhein et al. [25], we apply a five-step dose calibration (0.5,…4.5 
Gy), applied with field sizes of 5x3cm²  in 5cm depth of RW3 within one autosequence of the 
record and verify (R&V) system Primeview & Lantis (Siemens) that exposes all fields to one 
film. It is important, during the corresponding ionization chamber measurement, to apply the 
complete sequence for the measurement of each individual subfield to account for scatter 
contributions from the remaining fields. As film and/or film processing changes with time, it 
is important to integrate the film calibration procedure into every film dosimetric 
investigation. The calibration procedure includes a non-linear fit of the optical density versus 
dose data. One remaining question is whether any field size dependence influences the 
determination of dose distributions by means of EDR2 film dosimetry. For this reason, we 
investigated the output factor variation with field size by means of  EDR2-film dosimetry, 
measured in a depth of 5 cm RW3  and compared it to ionization chamber based output 
factors (OFs). The result is shown in Figure 5, revealing a slight difference in OF of up to 2% 
in the quadratic field size range of 2-20 cm, which makes EDR2 film dosimetry still suitable 
for IMRT-verification in agreement with several other investigators (e.g. [7, 32]. 
 
Determination of the absolute dose in a dose reference point by means of ionization chamber 
dosimetry was done using a 0,3 cm³ thimble chamber (M23332/Unidos, PTW). Absolute 
dosimetry in IMRT verification is under discussion because of the necessity of spatial 
positioning with high precision for comparisons with treatment plans. As IMRT plans  
normally show a larger dose inhomogeneity than 3-D CRT plans, dose gradients can be high 
across modulation sizes down to 1x1 cm2. To avoid volume effects due to inhomogeneity of 
the dose distribution, many authors suggest to use chambers with small volumes.  For our 
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own investigations we defined a cylindrical volume of interest (VOI) in a highly 
homogeneous region of the dose cube with an appropriate size to account for chamber 
volume and setup errors. Thus, we rid ourselves of the necessity to position a very small 
volume probe with highest precision.  
.  
MR Gel dosimetry is another new field under investigation for IMRT verification purposes, as 
described above. This not only for class solution verifications, but also for individual 
dosimetry within a transfer phantom. The method is, in principle, capable of delivering a true 
3-D dose distribution within any phantom shape, filled with a homogeneous polymer gel, 
such avoiding the danger of undetecting hot or cold spots (e.g., [6, 12]). 
 
Finally, the use of Monte Carlo simulation for verification purpose, as described above, can 
be just as valuable for individual patient verification as for class solutions. But, of course, a 
code must be found, which is quick and precise enough, to deliver treatment plans for 
verification purpose within a reasonable time frame. We use XVMC, including the MC 
treatment head model VEF, as described by Fippel et al. [9-11], which we commissioned 
with data from our linac (Primus, Siemens) for 6 MV photons. The MC code is integrated in 
our inverse MC optimisation programs, called IMCO++/IKO, described by Hartmann et al. 
[13, 14]. For verification purposes, the optimization is switched off, and XVMC/VEF is used 
for forward calculations of all beam segments as determined by the pencil-beam based IMRT 
treatment plan (TMS,Theranostic) and transferred via DICOM-RT. 
 
Finally, all verification work requires the comparison of calculations with  measurements of 
fluence in a slab phantom or dose distributions in a suitable transfer phantom. To be highly 
flexible in redefining evaluation goals we have developed our own verification software 
(IMRT-verif) by means of Matlab (MathWorks) similar to others [29].  It accepts data in 
the DICOM-RT standard, using fiducial points (Figure 1) for matching, tilting, and rescaling 
picture resolution and normalization of pixel contents, etc. The evaluation procedure delivers 
a comparison of the processed raw data, its absolute and relative dose difference, and, 
additionally, a modified plot of absolute gamma values [21], with arrows per pixel, indicating 
the direction and size of distance-to-agreement deviation.  
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Results 
When starting with IMRT treatment of patients in our clinics in 2002, we preferred to use 
different and independent verification methods to reveal  any possible sources of error. So we 
have applied EDR2 film fluence verification for the modulated beams. Figure 7 shows the 
result of a comparison of the measured and calculated fluence-proportional profiles of one 
modulated beam of the treatment plan, shown in Figure 6. It is composed of ten segments of a 
seven-beam IMRT plan with altogether 70 segments, applied to a slab phantom in 5 cm 
depth. 
 
As second method, the verification by means of a cylindrical transfer phantom (Figure 1), as 
described above, was applied routinely to every IMRT patient plan. At first an absolute dose 
determination in one point of the transfer phantom, using IC or diode-dosimetry, was done, 
yielding a measured dose about 5-7% too low in all cases investigated so far.  This absolute 
dose value was used to correct the monitor units of all segments in the further relative 
dosimetry investigation. In Figure 8a, the result of the evaluation of one of five axial EDR2 
verification-films is shown, calibrated to absolute dose. The evaluation of the differences in 
this slice to TMS calculation in terms of relative dose difference (Figure 8b) and gamma plot 
(Figure 8c) with a distance of agreement of 3 mm and 3% of dose shows a relative good 
agreement, with the exception of edge effects and hot spots. The absolute dose correction 
factor has been applied to the monitor units (Mus) of the patient treatment plan, as well. 
 
The evaluation of the verification of five patient treatment plans, three of which had been 
calculated with a sequential boost and two with a SIB-technique [27, 31], showed  absolute 
dose deviations, which seemed to depend on the number of segments.  In five IMRT plans 
with about 70 segments we found deviations of -6% (± 1,0%), whereas two boost cases with 
30 segments somehow resulted in lower deviations of –5% (±1%). The external segmentation 
software IMfast (Siemens, [28]) was used to investigate if any dependence of absolute dose 
deviation from the number of segments for the same treatment plan exists. Starting from a 
TMS calculation with the built-in segmentation algorithm switched off, the resulting fluence 
distribution was externally segmented by IMfast with different restrictions to the number of 
segments. These plans were then transferred to the transfer phantom, followed by a 
comparison of absolute dose measurement to calculation. A comparison of two plans with 95 
(on average 13.5 per gantry angle) and 29 (4.1 per beam) segments yielded a measured 
underdosage of 7.1% and 5.7%. A simple IMRT example of  nine non-overlapping segments 
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of 3 x 3 cm2  composing a 9 x 9 cm2  field also showed a lower dose, when calculated as 
IMRT beam. The closer intercomparison of TMS 6.1A calculation as modulated rather than 
as “normal beams” revealed a 2.6 – 3.4% (for two “different” Siemens Primus linacs) dose 
error due to approximations made for IMRT beams. As a result, all these comparisons did not 
confirm a dependence of the dose difference on the total number of segments. 
 
Large deviations can be found when investigating relative dose profiles normalized to 10x10 
cm² for very small IMRT segments by means of different calculations (TMS PB [pencil 
beam], CC [collapsed cone] and different dose probes (diode, pin-point IC, IC15, EDR2). In 
Figure 9, a small segment which fulfils the minimal requirements of TMS IMRT (aperture 
with > 9 cm² and more than two leaf pairs open) is investigated, yielding dose deviations up 
to 9% for the pin-point IC and 5% for EDR2, respectively, when compared to the diode as a 
reference probe. The calculation deviates up to 2.5% for PB and 5% for CC, respectively. 
 
Small field dosimetry on quadratic fields showed that TMS compares well with diamond 
measurements down to 2x2 cm2 (Figure 10). At 1x1 cm2 the TMS 6.1A result gives a 23% 
lower output when compared to the diamond probe. Diode shows a 11% higher dose 
response, the 0,3 cm³ ionisation chamber is completely off due to the detector size. Another 
measurement revealed that a microionisation chamber with steel electrode (pin point) showed 
about 15% less dose than diamond at 1.2x1.2 cm2. 
 
Nucletron B.V. has improved the head model in TMS 6.1B, using our small-field data 
measured with a diamond detector. A TMS6.1B test with smaller and slightly elliptic source 
sizes (diameter of 0.265 and 0.235 cm, respectively, compared to 0.48 cm in TMS 6.1A) 
showed that, even at 1x1 cm2, the output can be accurately modelled.  
 
Application of the new model to a patient case for comparison with the old model, strongly 
supports that small-field problems play a minor role, but instead, it is additional dose 
calculation approximations, which are only applied in IMRT (Murmann 2003, personal 
communication), which seem to play the major role. 
 
In investigating the origin of the absolute dose deviation, additional research was done  to 
determine how MLC misalignment influences absolute dose. Since MLC tolerance tables  
allow a ± 2 mm deviation of the nominal leaf position, we looked for the differences in 
absolute dose of the 70-segment patient plan when adding or subtracting 2 mm to every leaf 
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within every segment as a worst case by means of a MC calculation. In doing so, we could 
detect a rather high influence of leaf position errors on the mean dose of about 8% (low by 
smaller and high by larger aperture) between both extremes (Figure 12). 
 
When regarding the time-consuming verification methods, the question arises if MC dose 
verification could be a serious alternative. In Figure 11, a comparison of PB-based TMS 
IMRT and XVMC/VEF  forward calculation of the TMS plan demonstrated (treatment plan 
of Figure 6) is shown in terms of dose-volume histograms (DVHs). The evaluation 
demonstrates that MC-calculation reveals dose differences, which must be attributed to the 
systematic and convergence errors [17] based on the PB approximations. 
 
Discussion 
A strategy for IMRT verification is presented and some of the methods proposed were 
applied to a real H&N IMRT treatment plan. The simultaneous application of relative fluence 
and dose verification in a transfer phantom in combination with absolute dose verification by 
IC or diode dosimetry is time-consuming, but it demonstrated its sensitivity for the detection 
of errors which can occur in the IMRT chain. Whereas the fluence distributions of the 
modulated beams and the relative dose are in general good agreement with the calculated 
ones, we revealed systematic deviations in the absolute dose at a reference point. Our search 
for the causes of these deviations can be divided into four parts: 
 
(1) Investigations of the probes used for the verification process showed clearly 
that for relative film dosimetry in a transfer phantom the EDR2 film is the 
only suitable one, whereas for relative fluence verification other films like X-
OMAT, EC-V are good as well. Investigations on probes for small-field 
absolute dose measurements showed that diodes and diamond detectors are 
suitable. IC-measured doses must be compared with averages of a suitably 
sized VOI around the dose reference point, chosen within a homogeneous area 
of the target. EDR2 film should not be used for absolute dosimetry, because its 
precision is restricted to ±3%, which is not high enough. 
 
 
(2) The penumbra structures of the narrow beamlets in the transfer phantom are 
broader in the TMS calculations when compared to EDR2,  as can clearly be 
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seen in Figure 8a. The reasons for this difference could be the poorer spatial 
resolution of the dose cube and/or an erroneously determined focal spot size of  
TMS. The commissioning data set consists of profiles using a 0.13 cm³ IC and 
output factors down to minimal field sizes of 5x5 cm2 according to TMS 
recommendations in version TMS 6.1A. OFs for smaller fields are 
extrapolated due to missing data. The focal spot size evaluation is based on the 
measurements of the 10x10cm2 field, which is usually done with a medium 
volume chamber, although a high resolution detector would be required for 
this purpose. A new head model with elliptic source size (TMS 6.1B) 
commissioned by diamond-based OFs down to 1 x 1 cm² yield a rather good 
agreement.High deviations could also be found in the investigation of 
extremely small irregular field sizes (but within TMS default IMRT settings) 
with respect to beam profiles and OFs, showing again the necessity to measure 
data down to smaller field sizes with suitable probes like diamond or diodes 
for TPS commissioning.  
 
(3) Our investigations strongly support that small-field problems play a minor 
role, but instead there are additional dose calculation approximations, which 
are only applied in IMRT (Murmann 2003, personal communication) which 
seem to play the major role. The dose deviations between measurement and 
calculation in a reference point in the transfer phantom and a simple IMRT 
test case demonstrated the TMS difference for IMRT calculation. “Normal 
beams” are calculated in TMS with fluence step functioned at field edge plus 
source blurring merged into the pencil beam kernel shape. Segmented 
multilieaf step-and-shoot modulation fields are handled differently than 
“normal beams”. The total fluence is calculated by summing all segments, 
step-functioned at each segments edge, not just at the total field edge. 
Accompanied by implementation errors in 6.0 and 6.1A, overblurring 
occurred, possibly leading to a difference in transmission modelling. Thus, 
increasing the number of segments could lead to the observed increase in dose 
difference. In OTP (Nucletron B.V.) the dose deviation vanishes, because all 
segments are calculated without further approximations. All suggested 
improvements in head modelling and TPS commissioning also hold true for 
XVMC/VEF. 
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(4) Finally our investigations on MLC misalignment within the allowed tolerance 
reveal a major impact in IMRT dose delivery. The errors can, in principle, be 
detected by the fluence verification, described above. In any case it is 
recommended to spend more time in MLC QA instead of in individual patient 
QA [4]. In addition to  the calibration of the leaves at gantry zero position, it 
should be checked whether the  MLC alignment depends on the gantry angle 
or on the moving direction of the leaf. A misalignment of the MLC not only 
affects the absolute dose, but could also affect the position of the dose 
distribution. Both could result in overdosage of the OAR and too low dose in 
the PTV. The same holds true for a detailed QA of the isocenter position. 
 
Realizing that special IMRT dose calculation approximations, treatment head modelling, and 
small-field dosimetry can offer a severe problem to IMRT TPS, including MC-based systems, 
special care must be taken in commissioning and verification, especially for small off-axis 
fields. It has to be emphasized that the manufacturer of a TPS must disclose all 
approximations of the IMRT algorithm, together with recommendations for base data 
measurement being sensitive to those. Moreover he must provide for a very detailed pre-
release commissioning of the TPS, together with his beta test sites, and supply the customer 
with the results of this. It must be sufficient for a hospital physicist to restrict himself to a 
post-release TPS commissioning, which only can be a subset. 
  
In spite of the discussed problems, IMRT is a method to spare the organs at risk and to get a 
sufficient dose in the PTV in one session [24, 30]. The classic irradiation technique for H&N 
tumors, on the other hand, claims multiple fields with over- or underdosage at field 
matchlines of electron and photon fields and does not allow sparing the parotids. Another 
source of error, relativizing the problems discussed in this paper, originates from the 
uncertainty of positioning, even when using a stereotactic mask system. 
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Conclusion 
The process of finding the most reliable verification process is perhaps close to its end. First 
the TPS, with its approximations and small-field behaviour, should be extensively verified 
after a very detailed commissioning phase. Second, an intensive MLC QA should be 
routinely run. Then, as a minimal individual verification concept, one should be able to 
reduce the procedure to either fluence or dose verification, but in both cases an absolute dose 
determination should be included for safety reasons. Both methods are sensitive to detect  
delivery problems.  
 
An MC system like XVMC/VEF is extremely useful as a tool to detect different sources of 
errors during the IMRT introduction phase of a distinct tumor site. Especially in the H&N or 
mediastinum region, pronounced systematic and convergence errors [17] can occur using the 
PB model. On the other hand, an MC system cannot be a verification tool for a PB-based 
TPS, as dose differences are a priori expected. So the only way to avoid the well-known 
problems of PB algorithm is to use inverse MC systems like IMCO++/IKO [3] or Hyperion 
[2] for IMRT. These systems avoid systematic and convergence errors completely, and an 
absolute dose verification should be done only for safety. Delivery can be controlled by an 
extended MLC QA and the interlock system. 
 
Acknowledgements 
This work was supported by the Deutsche Forschungsgemeinschaft. We want to thank A. 
Murman and A. Ahnesjö from Nucletron B.V. for supporting us with the head model 
calculations and other fruitful discussions.  
 
 
 
Address for Correspondence 
Priv.-Doz. Dr. Ludwig Bogner, PhD 
Departement of Radiotherapy 
University of Regensburg 
Franz-Josef-Strauß-Allee 11 
93042 Regensburg 
Germany 
 
Strahlenther Onkol 2004;180:340-50, DOI 10.1007/s00066-004-1219-0 
 16
Literature: 
 
1. Ahnesjö A, Aspradakis MM. Dose calculations for external beams in radiotherapy. 
Phys Med Biol 1999; 44: R99-R155 
 
2. Alber M, Birkner M, Laub W, Nüsslin F. Hyperion – An integrated IMRT planning 
tool. In: Schlegel W, Bortfeld T, Hrsg. The Use of Computers in Radiation Therapy, 
Berlin-Heidelberg-New York: Springer, 2000:46-8 
 
3. Bogner L, Hartmann M . Inverse kernel methods in inverse treatment planning. 2004: 
manuscript in preparation 
 
4. Bohsung J, Groll J et al.  IMRT mit dynamischem MLC – Erfahrungen nach mehr als 
einem Jahr klinischer Routine. In: Welker K, Zink K., Hrsg., Medizinische Physik 
2001, Berlin: DGMP, 2001: 165-6 
 
5. Boyer AL, Butler EB, DiPetrillo TA et al. Intensity-modulated radiotherapy : current 
status and issues of interest. Int J Radiat Oncol Biol Phys 2001; 51,4: 880-914 
 
6. De Deene Y : Gel dosimetry for the dose verification of intensity modulated 
radiotherapy treatments. Z Med Phys 2002; 12: 77-89 
 
7. Esthappan J, Sasa M, Harms WB et al. Dosimetry of therapeutic photon beams using 
an extended dose range film. Med Phys 2002; 29(10): 2438-45 
 
8. Ezzell GA, et al. Guidance document on delivery, treatment planning, and clinical 
implementation of IMRT: report on the IMRT Subcommitee of the AAPM Radiation 
Therapy Committee. Med Phys 2003;30:2089-115 
 
9. Fippel M. Fast Monte Carlo dose calculation for photon beams based on the VMC 
electron algorithm. Med Phys 1999;26:1466-75 
 
10. Fippel M, Haryanto F, Dohm O, et al. A virtual photon energy fluence model for 
Monte Carlo dose calculation. Med Phys 2003;30:301-11 
 
11. Fippel M, Laub W, Huber B, et al. Experimental investigation of a fast Monte Carlo 
photon beam dose calculation algorithm. Phys Med Biol 1999;44:3039-54 
 
12. Gum F, Scherer J, Bogner L, et al. Preliminary study on the use of an inhomogeneous 
anthropomorphic Fricke gel phantom and 3D magnetic resonance dosimetry for 
verification of IMRT treatment plans. Phys Med Biol 2002;47:67-77 
 
13. Hartmann M., Bogner L. IKO – a new Monte Carlo based treatment planning system. 
2004: manuscript in preparation 
 
14. Hartmann M, Bogner L, Fippel M. IMRT: Inaccuracies of a conventional inverse 
pencil beam TPS, obtained by a comparison with a Monte-Carlo based TPS. 
Radiother Oncol 2002; 64:Suppl.1:S96 
 
 
 
Strahlenther Onkol 2004;180:340-50, DOI 10.1007/s00066-004-1219-0 
 17
15. Hartmann M, Bogner L, Fippel M et al. IMCO++ - Ein Monte-Carlo-basiertes System 
für die IMRT. Z Med Phys 2002;12:97-108 
 
16. Hunt MA, Zelefsky MJ, Wolden S et al. Treatment planning and delivery of intensity-
modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol 
Phys 2001;49,3:623-32 
 
17. Jeraj R, Keall PJ, Siebers JV. The effect of dose calculation accuracy on inverse 
treatment planning, Phys Med Biol 2002;47:391-407 
 
18. Johns HE, Cunningham JR. Measurement of radiation: Dosimetry. In: The Physics of 
Radiology, Fourth Edition. Springfield: Thomas, 1983:217-69 
 
19. Laub W, Wong T. The volume effect of detectors in the dosimetry of small fields 
used in IMRT. Med Phys 2003;30:341-7 
 
20. Leal A, Sanchez-Doblado F, Arrans R et al. Routine IMRT verification by means of 
an automated Monte Carlo simulation system. Int J Radiat Oncol Biol Phys 
2003;56:58-68 
 
21. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation 
of dose distributions. Med Phys 1998; 25: 656-61 
  
22. Ma  CM, Pawlicki T, Jiang SB et al. Monte Carlo verification of IMRT dose 
distributions from a commercial treatment planning optimisation system. Phys Med 
Biol 2000; 45: 2483-95 
 
23. MacKenzie MA, Lachaine M, Murray B et al. Dosimetric verification of inverse 
planned step and shot multileaf collimator fields from a commercial treatment 
planning system. J Appl Clin Med Phys 2002;3:97-109 
 
24. Münter MW, Debus J, Hof H et al. Inverse treatment planning and stereotactic 
intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for 
nasopharyngeal carcinomas. Strahlenther Onkol 2002;178:517-23 
 
25. Rhein B, Häring P, Debus J, Schlegel W. Dosimetrische Verifikation von IMRT-
Gesamtplänen am Deutschen Krebsforschungszentrum. Z Med Phys 2002;12:122-32 
 
26. Scherer J, Solleder M, Schiessl I et al. 3D MR-Gel-Dosimetrie mit 
lungenäquivalentem Gel.  Z Med Phys 1998;4:201-208  
 
27. Schulz-Ertner D, Didinger B, Nikoghosyan A, et al. Optimization of radiation therapy 
for locally advanced adenoid cystic carcinomas with infiltration of the skull base 
using photon intensity-modulated radiation therapy (IMRT) and carbon ion boost. 
Strahlenther Onkol 2003;179:345-51 
 
28. Siochi RA. Minimizing static intensity modulation delivery time using an intensity 
solid paradigm. Int J Radiat Oncol Biol Phys 1999;43:671-80 
 
29. Wiezorek T, Schwedas M, Scheithauer M et al. VERIDOS: A new tool for quality 
assurance for intensity modulated radiotherapy. Strahlenther Onkol 2002;178:732-36 
Strahlenther Onkol 2004;180:340-50, DOI 10.1007/s00066-004-1219-0 
 18
 
30. Wu Q, Manning M, Schmidt-Ullrich R et al. The potential for sparing of parotids and 
escalation of biologically effective does with intensity-modulated radiation treatments 
of the head and neck cancers; a treatment design study. Int J Radiat Oncol Biol Phys 
2000;46:193-205 
 
31. Wu Q, Mohan R, Morris M et al. Simultaneous integrated boost intensity-modulated 
radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: 
dosimetric results. Int J Radiat Oncol Biol Phys 2003;56:573-85 
 
32. Zhu XR, Jursinic PA, Grimm DF et al. Evaluation for Kodak EDR2 film for dose 
verification of intensity modulated radiation therapy delivered by a static multileaf 
collimator. Med Phys 2002; 29(8): 1687-92 
Strahlenther Onkol 2004;180:340-50, DOI 10.1007/s00066-004-1219-0 
 19
Figures: 
 
Figure 1 Scheme of a cylinder phantom as transfer phantom suitable for H&N-IMRT 
verification, demonstrating the production of fiducial markers on the film. 
Abbildung 1 Schema eines Transfer-Zylinderphantoms für Kopf-Hals-Tumoren mit 
Darstellung der Anbringung von Orientierungsmarkierungen auf dem Film. 
 
 
Figure 2 Comparison of the dose-response of different radiographic films. 
Abbildung 2  Vergleich der optischen Dichte verschiedener Filmtypen als Funktion der 
Dosis. 
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Figure 3 Dependence of the EDR2 (Kodak) dose-response curve from phantom depth 
Abbildung 3  Die optische Dichte als Funktion der Dosis für den EDR2 – Film in 
verschiedenen Tiefen. 
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Figure 4  Comparison of depth dose curves, measured with EDR2 film dosimetry versus 
ionization chamber (top). Dose differences between ionisation chamber versus 
EDR2 (bottom). 
Abbildung 4  Tiefendosiskurven mit EDR2-Filmdosimetrie versus Ionisationskammer 
(oben). Dosisdifferenzen zwischen der Ionisationskammer und EDR2 (unten). 
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Figure 5  Comparison of EDR2 film dosimetry and IC based outputfactors of quadratic 
field sizes, measured in a depth of 5 cm (top) and OF-difference (bottom). 
Abbildung 5  Outputfaktoren als Funktion der Quadratfeldgröße in 5 cm Tiefe, bestimmt mit 
EDR2 Film und Ionisationskammer (oben) und deren Differenz (unten).
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Figure 6  H&N-IMRT plan calculated by TMS version 6.1A. The plan consists of  seven 
modulated beams in half-beam technique. A conventional anteroposterior 
supra-half-beam is integrated by beam weight optimisation alone. Three-plane 
dose distribution is shown. 
Abbildung 6 H&N- IMRT-Plan berechnet mit TMS Version 6.1A. Der Plan besteht aus 
sieben modulierten Feldern in Halbfeldtechnik; ein konventionelles 
anteroposteriores-Supraclavicularfeld wird nur gewichtsoptimiert kaudal als 
Halbfeld angeschlossen. Darstellung einer Dosisverteilung in drei Ebenen. 
 
 
Strahlenther Onkol 2004;180:340-50, DOI 10.1007/s00066-004-1219-0 
 24
Figure 7 Fluence verification by means of EDR2 film dosimetry and its evaluation. 
Measured and calculated fluence-proportional profiles, normalized to their 
maxima. 
Abbildung 7 Fluenzverifikation mittels EDR2 – Filmdosimetrie: Gemessene und berechnete 
fluenz-proportionale Profile, normiert auf ihre Maxima. 
 
8a 
8b 
8c 
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Figure 8a to 8c Dose verification of the IMRT plan in the transfer phantom. a) film and 
calculated absolute dose distribution in one distinct slice. b) relative difference 
of the dose distributions. c) Gamma plot. 
Abbildung 8a bis 8c  Dosisverifikation eines IMRT-Plans im Transferphantom. a) Film und 
berechnete Absolutdosisverteilung in einer Schichte. b) relative Differenz der 
beiden Dosisverteilungen. c) Gammaplot. 
 
Figure 9  Dose profile for the shown small irregular field, measured by diode, IC15,, pin-
point IC, IC15, and EDR2 film, normalized to 10x10 cm2. Additionally shown 
are calculations by means of pencil beam  and collapsed cone (TMS, Nucletron 
B.V.) algorithms.   
Abbildung 9  Dosisprofile für ein kleines irirreguläres Feldsegment, gemessen mit Diode, 
IC15, Pin- Point IC, IC15 und EDR2 Film, normiert auf 10x10 cm2. Zusätzlich 
werden Berechnungen mit Pencil Beam und Collapsed Cone (TMS, Nucletron 
B.V.) gezeigt. 
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Figure 10  Absolute dose (output) as a function of field size: Comparison of 0.3 cm³ IC, 
diamond, diode and TMS 6.1A und 6.1B calculations. 
Abbildung 10 Absolutdosis (Output) als Funktion der Feldgröße: Vergleich von 0.3 cm³ IC, 
Diamant und Diode mit TMS-6.1A- und -6.1B-Rechnungen. 
 
 
Figure 11 MC verification of the IMRT treatment plan of figure 6 by means of Figure 6 by 
means of XVMC/VEF by dose-volume histograms of planning target volume, 
spinal cord, and right parotid gland 
Abbildung 11 MC Verifikation des IMRT-Plans aus Abbildung 6 mittels XVMC/VEF durch 
Dosis-Volumen-Histogramme des Planungszielvolumens, Rückenmarks und der 
rechten Parotis. 
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Figure 12 MC simulations of the MLC misalignment, demonstrated by means of the 
treatment plan of Figure 6: The histogram of [100x (dose with deviating leaf 
positions – dose with optimal leaf positions)/dose with optimal leaf positions] is 
shown. Left: all leaves of all segments opened by 2 mm. Right: all leafs closed 
by 2 mm. 
Abbildung 12 MC-Simulationen zur MLC-Dejustierung am Beispiel der Dosisverteilung des 
Planes aus Abbildung 6: Dargestellt ist die Histogrammverteilung der Größe 
[100x (Dosis bei abweichenden MLC-Positionen – Dosis bei optimalen MLC-
Positionen)/Dosis bei optimalen MLC-Positionen)]. Links: alle Leaves aller 70 
Segmente um 2 mm geöffnet. Rechts: alle Leaves um 2 mm geschlossen.  
  
 
